SIETES :: 92954 citas

Resultados de la búsqueda por CITOCROMO P450 REFINAR BÚSQUEDA

1.

Abrams DI, Guzmán M. Can cannabis cure cancer?1. JAMA Oncology 2020:1. [Ref.ID 103508]

2.

Anónimo. FDA approves new treatment for adults with migraine. U.S. Food and Drug Administration 2019:23 de diciembre. [Ref.ID 103240]

3.

Parthipan A, Banerjee I, Humphreys K, Asch SM, Curtin C, Carroll I, Hernandez-Boussard T. Predicting inadequate postoperative pain management in depressed patients: a machine learning approach. PLoS One 2019;14:6 de febrero. [Ref.ID 103058]

4.

Newman CB, Preiss D, Tobert JA, Jacobson TA, Page II RL, Goldstein LB, Chin C, Tannock LR, Miller M, Raghuveer G, Duell PB, Brinton EA, Pollak A, Braun LT, Welty FK. Statin safety and associated adverse events: a scientific statement from the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology 2019;39:enero. [Ref.ID 103011]

5.

Ham AC, van Dijk SC, Swart KMA, Enneman AW, van der Zwaluw NL, Brouwer-Brolsma EM, van Schoor NM, Zillikens MC, Lips P, de Groot LCPGM, Hofman A, Witkamp RF, Uitterlinden AG, Stricker BH, van der Velde N. Beta-blocker use and fall risk in older individuals: Original results from two studies with meta-analysis. Br J Clin Pharmacol 2017;83:2292-302. [Ref.ID 102082]

6.

Devinsky O, Cross JH, Wright S. Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. N Engl J Med 2017;377:699-700. [Ref.ID 102019]

7.

Tang R, Fang F. Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. N Engl J Med 2017;377:699. [Ref.ID 102018]

8.

Hammann F, Gotta V, Conen K, Medinger M, Cesana P, Rochlitz C, Taegtmeyer AB. Pharmacokinetic interaction between taxanes and amiodarone leading to severe toxicity. Br J Clin Pharmacol 2017;83:927-30. [Ref.ID 101972]

9.

Nalla P, Dacruz TA, Obuobie K. Tiredness in a patient treated with itraconazole. BMJ 2017;356:i6819. [Ref.ID 101383]

10.

Wang Y, Zhao X, Lin J, Johnston C, Lin Y, Pan Y, Liu L, Wang D, Wang C, Meng X, Xu J, for the CHANCE Investigators. Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack. JAMA 2016;316:70-8. [Ref.ID 100516]

11.

Anónimo. Cannabis and cannabinoids. Med Lett Drugs Ther 2016;58:97-8. [Ref.ID 100510]

12.

Woloshin S, Schwartz LM. US Food and Drug Administration approval of flibanserin. Even the score does not add up . JAMA Intern Med 2016;176:439-42. [Ref.ID 100071]

13.

Anónimo. FDA approves new drug treatment for nausea and vomiting from chemotherapy. U.S. Food and Drug Administration 2015:2 de septiembre. [Ref.ID 99434]

14.

Herman AO. FDA approves drug for hypoactive sexual desire disorder in women. Journal Watch 2015:1. [Ref.ID 99407]

15.

Anónimo. Gluconorm (repaglinide) - New contraindication for concomitant use with clopidogrel . Healthy Canadians 2015:31 de julio. [Ref.ID 99386]

16.

Young K. FDA advisers back approval of first drug for female sexual dysfunction. Journal Watch 2015:1. [Ref.ID 99241]

17.

Anónimo. Which PPI?. Med Lett Drugs Ther 2015;57:8-9. [Ref.ID 99216]

18.

Anónimo. Codeine for cough and cold: restricted use in children. Drug Safety Update 2015;8:2. [Ref.ID 99022]

19.

Anónimo. Suvorexant (Belsomra) for insomnia. Med Lett Drugs Ther 2015;57:29-31. [Ref.ID 98878]

20.

Degner D. Severe adverse reactions associated with quetiapine. BMJ 2015;350:h1575. [Ref.ID 98872]